[1] Carlson LA,Olsson AG.Intravenous prostaglandin E1 in severe vascular diseases.Lancet,1976,2,810.
[2] Morisaki S.Effects of topical aPPlication of prostaglandin E1 ointtnent on chronic skin ulcers and relation between tissue oxygen tension and lts clinical efficacy.Skin Res (Japanese),1993,35(Suppl):210.
[3] Wahl SM,Wong H,McCartney-Francls N.Roles of growth factors in inflammation and repair.J Cell Biochem.1989.40:193.
[4] Hom DB,Maisel RH.Angiogenic growth factors:their effects and potential in soft tissue wound healing Ann Otol Rhinol Lanryngol,1992,101:349.
[5] Dutta-Roy AK。Sinha AK Purification and proPerties of prostaglandin El/prostacyclin receptor of human platelets,J Biol Chem,1987,262:12685.
[6] KloezeJ,Influence of prostaglandin on Platelet adhesiveness and platelet aggregation.In:Bergstrom S,eds.Nobel symposiumZ:Prostaglandins,Stockholm:Almqvist wik-sell,1991:241-252.
[7] Sauder DN.The role of ePidermal cytokines in inflammatory skin diseases.J Invest Dermatol,1990,95:275.
[8] Kruegger JG,Krane JF,Carter DM.et al.Roleofgrowth factors,cytokines and their receptors In the Pathogenesis of Psoriasis.J Investl)ermatol,1990,94: 1355.
[9] TuschilA,LamC,HasbergerA,et al.Interleukin-8 stimulates calcium transients and promotes epidermal cell prolif-eration.]Invest Dermatol,1992.99:294. |